Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Starting to move.

<< Previous

Bullboard Posts

Next >>

Comment by kevlin139on Jul 24, 2020 12:04pm

40 Views

Post# 31314615

RE:RE:Starting to move.

hang in there biglicka... dont loose your $hit... calm stay calm

bligicka wrote: Ridiculous pp ruined this stocks momentum as all other Biotechnology stocks are rocking were just stagnating for the rest of the summer ....pp will probably be extended again ...what a joke this Ceo is !!!

kevlin139 wrote: Volume is coming in news on pp closing must be vlose. Maybe other news with it